Manulife (Manufacturers Life Insurance)
AVEO

Manulife (Manufacturers Life Insurance)’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,275
Closed -$97K – 3383
2021
Q1 		$97K Buy
+13,275
New +$115K ﹤0.01% 3047
2020
Q4 		– Sell
-12,584
Closed -$75K – 3093
2020
Q3 		$75K Buy
+12,584
New +$62.3K ﹤0.01% 2855
2019
Q1 		– Sell
-6,857
Closed -$109K – 2674
2018
Q4 		$109K Sell
6,857
-486
-7% -$10.7K ﹤0.01% 2432
2018
Q3 		$243K Sell
7,343
-1,086
-13% -$27.9K ﹤0.01% 2641
2018
Q2 		$191K Buy
8,429
+8,066
+2,222% +$191K ﹤0.01% 3162
2018
Q1 		$11K Buy
363
+42
+13% +$1.23K ﹤0.01% 3895
2017
Q4 		$9K Buy
321
+20
+7% +$621 ﹤0.01% 4023
2017
Q3 		$11K Buy
301
+198
+192% +$6.12K ﹤0.01% 3817
2017
Q2 		$2K Sell
103
-16
-13% -$126 ﹤0.01% 4160
2017
Q1 		$1K Hold
119
– – ﹤0.01% 4137
2016
Q4 		$1K Hold
119
– – ﹤0.01% 4280
2016
Q3 		$1K Hold
119
– – ﹤0.01% 4224
2016
Q2 		$1K Hold
119
– – ﹤0.01% 4182
2016
Q1 		$1K Hold
119
– – ﹤0.01% 4056
2015
Q4 		$2 Hold
119
– – ﹤0.01% 3834
2015
Q3 		$1 Hold
119
– – ﹤0.01% 3986
2015
Q2 		$2 Hold
119
– – ﹤0.01% 3843
2015
Q1 		$2 Hold
119
– – ﹤0.01% 3839
2014
Q4 		$1 Hold
119
– – ﹤0.01% 3877
2014
Q3 		$1 Hold
119
– – ﹤0.01% 3892
2014
Q2 		$2K Sell
119
-3,572
-97% -$46.5K ﹤0.01% 3722
2014
Q1 		$55 Sell
3,691
-655
-15% -$11.8K ﹤0.01% 3198
2013
Q4 		$80 Buy
4,346
+44
+1% +$881 ﹤0.01% 3132
2013
Q3 		$89 Buy
4,302
+83
+2% +$1.9K ﹤0.01% 3063
2013
Q2 		$106K Buy
+4,219
New +$180K ﹤0.01% 2993

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AVEO Position: Q2 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2021, closing a stake of 13,275 shares — an estimated $97K sold.

Manulife (Manufacturers Life Insurance) first reported a position in AVEO in Q2 2013 and held it in 25 quarters. The position peaked at $243K in Q3 2018. 63 funds tracked by Wall St. Rank hold AVEO as of Q2 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 13,275 AVEO Pharmaceuticals, Inc. shares in Q2 2021, an estimated $97K.
  • Manulife (Manufacturers Life Insurance) first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 25 quarters.
  • Manulife (Manufacturers Life Insurance)'s AVEO Pharmaceuticals, Inc. position peaked at $243K in Q3 2018.
  • 63 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2021, filed 12 Aug 2021.